Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

55.63
Delayed Data
As of Jul 22
 +0.61 / +1.11%
Today’s Change
46.17
Today|||52-Week Range
60.34
-4.22%
Year-to-Date
No recent news for Novo Nordisk.

Today’s Trading

Previous close55.02
Today’s open55.37
Day’s range55.21 - 55.64
Volume638,844
Average volume (3 months)1,260,744
Market cap$109.1B
Dividend yield1.72%
Data as of 4:01pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)+12.05%
Earnings growth (this year)--
Earnings growth (next 5 years)+12.29%
Revenue growth (last year)+1.43%
P/E ratio4.1
Price/Sales9.38
Price/Book20.73

Competitors

 Today’s
change
Today’s
% change
SNYSanofi+0.41+0.98%
GSKGlaxoSmithKline+0.28+0.64%
ABBVAbbVie-0.08-0.13%
AGNAllergan+1.14+0.46%
Data as of 4:02pm ET, 07/22/2016

Financials

Next reporting dateAugust 5, 2016
EPS forecast (this quarter)$0.58
Annual revenue (last year)$16.0B
Annual profit (last year)$5.2B
Net profit margin32.30%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Rebien Sørensen
Chief Financial Officer &
Executive Vice President
Jesper Brandgaard
Corporate headquarters
Bagsværd, Capital Region

Forecasts

Partner Offers

Search for Jobs